Forward focused thinking
Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
Filter articles
The biofuel cell – breathing new life into portable electronics?
|16th August 2016
Associate Medical Copywriter Kulveer Singh explains how biofuel cells work, why they are an exciting alternative to normal battery power, and what the challenges are in implementing their use.
Products as portfolios: positioning immuno-oncology products
|8th August 2016
The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning in this situation is vital to cut through the noise, so we've outlined some key learnings from our extensive experience in this area.
European prostate cancer treatment is changing - what are the opportunities for marketers?
|3rd August 2016
In this article, Consultant Jeremy Poland examines some of the key dynamics in prostate cancer multi-disciplinary teams across Europe and how the recent trends impact the opportunities available to healthcare marketers.
Immunotherapy in oncology
|27th July 2016
In this article, Consultant David Cooney explores the medical insights, unmet needs, and future of the vastly growing area of immunotherapy as the fourth pillar in oncology.
Why we work
|20th July 2016
A personal look at the drive and motivations behind our work at Blue Latitude Health from co-founder and Head of Strategy Fred Bassett.
Alzheimer's: the numbers we cannot forget
|19th July 2016
In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.
Biosimilars - the Brexit of the pharmaceutical industry?
|13th June 2016
In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities of Britain exiting the EU (Brexit).
Why isn’t your segmentation working?
|8th June 2016
Senior Associate Consultant Frances Hendry and Senior Customer Experience Consultant Peter Timmer take a closer look at why audience segmentations usually fail, and how you can make your segmentation actionable so that it can deliver real commercial value.
The role of empathy in the design of products and services
|31st May 2016
In this article, Customer Experience Consultant Peter Timmer talks through what it means to design with empathy for the customer, and why it produces better products and services for pharma and healthcare.
Experience design of physical spaces: a human-centred approach
|25th May 2016
Good user experience (UX) design considers how people feel about products and services and caters for their needs – and space design works exactly the same way. In this article, Consultant Anna Tamasi highlights the key considerations and best practices for spatial design from a user experience design perspective.
Previous
